| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/10/2004 | WO2004049234A1 Method of identifying disease-sensitivity gene and program and system to be used therefor |
| 06/10/2004 | WO2004048973A1 Method of fixing biomolecule on metal support |
| 06/10/2004 | WO2004048938A2 Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators |
| 06/10/2004 | WO2004048937A2 Electro-optical nucleic acid-based sensor array and method for detecting analytes |
| 06/10/2004 | WO2004048935A2 Detection of protease enzymes |
| 06/10/2004 | WO2004048933A2 Methods for diagnosing rcc and other solid tumors |
| 06/10/2004 | WO2004048931A2 Compositions, methods and kits for polynucleotide amplification reactions and microfluidic devices |
| 06/10/2004 | WO2004048928A2 Method and apparatus for performing multiple simultaneous manipulations of biomolecules in a two-dimensional array |
| 06/10/2004 | WO2004048925A2 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION |
| 06/10/2004 | WO2004048615A1 Method for the detection of newly acquired hiv infection |
| 06/10/2004 | WO2004048614A1 Detection of methylated dna sites |
| 06/10/2004 | WO2004048613A2 Dual assay for evaluating activity and cytotoxicity of compounds in the same |
| 06/10/2004 | WO2004048612A2 Bridge-probes for detecting non-contiguous cis-located acd sequences |
| 06/10/2004 | WO2004048611A2 Nucleic acid probes and method for detecting a target nucleic acid sequence comprise two or more cis- located nucleic acid regions |
| 06/10/2004 | WO2004048610A1 Methods of diagnosing and treating diabetes and obesity |
| 06/10/2004 | WO2004048609A2 Methods and kits for the selection of animals having certain mild production capabilities, based on the analysis of a polymorphism in the growth hormone receptor gene |
| 06/10/2004 | WO2004048608A1 Novel real-time rt-pcr for the sensitive detection of multiple mage gene transcripts |
| 06/10/2004 | WO2004048607A1 Method for the identification of sulfo-reducing bacteria |
| 06/10/2004 | WO2004048606A2 Porcine polymorphisms and methods for detecting them |
| 06/10/2004 | WO2004048604A1 Method of screening compound inhibiting enzymatic activity of gwt1 gene product |
| 06/10/2004 | WO2004048603A2 Coatings |
| 06/10/2004 | WO2004048602A1 Device for determining the activity of enzymes |
| 06/10/2004 | WO2004048596A2 Methods for using primers that encode one strand of a double-stranded promoter |
| 06/10/2004 | WO2004048595A2 Vascular-preferred promoters |
| 06/10/2004 | WO2004048594A2 Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences |
| 06/10/2004 | WO2004048593A2 Methods for using riboprimers for strand displacement replication of target sequences |
| 06/10/2004 | WO2004048591A2 Methods for cohort selection and longevity studies |
| 06/10/2004 | WO2004048583A2 Compositions and systems for the regulation of genes |
| 06/10/2004 | WO2004048578A1 Soluble notch-based substrates for gamma secretase and methods and compositions for using same |
| 06/10/2004 | WO2004048577A1 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer |
| 06/10/2004 | WO2004048572A1 Type 2 diabetes-associated gene |
| 06/10/2004 | WO2004048568A1 UTILIZATION OF mKank GENE IN CANTER THERAPY, CANER DETECTION AND DRUG DISCOVERY |
| 06/10/2004 | WO2004048567A2 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 06/10/2004 | WO2004048566A1 Method of detecting target base sequence of rna interference, method of designing polynucleotide base sequence causing rna interference, method of constructing double-stranded polynucleotide, method of regulating gene expression, base sequence processing apparatus, program for running base sequence processing method on comp |
| 06/10/2004 | WO2004048564A1 Device for pretreating specimen |
| 06/10/2004 | WO2004048558A2 Heparanase mediated cell adhesion and uses thereof |
| 06/10/2004 | WO2004048555A1 Restoration of methylation states in cells |
| 06/10/2004 | WO2004048551A2 Target for therapy of cognitive impairment |
| 06/10/2004 | WO2004048548A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004048546A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004048544A2 Ca ix-specific inhibitors |
| 06/10/2004 | WO2004048542A2 Mapks as modifiers of the rac, axin, and beta-catenin pathways and methods of use |
| 06/10/2004 | WO2004048541A2 Cct6s as modifiers of the rb pathway and methods of use |
| 06/10/2004 | WO2004048540A2 Mracs as modifiers of the rac pathway and methods of use |
| 06/10/2004 | WO2004048539A2 Mapcaxs as modifiers of the apc and axin pathways and methods of use |
| 06/10/2004 | WO2004048538A2 Csnks as modifiers of the rac pathway and methods of use |
| 06/10/2004 | WO2004048536A2 Rhebs as modifiers of the rb pathway and methods of use |
| 06/10/2004 | WO2004048532A2 Inferring gene regulatory networks from time-ordered gene expression data using differential equations |
| 06/10/2004 | WO2004048528A2 Sampling method and apparatus for amplification reaction analysis |
| 06/10/2004 | WO2004048524A2 Modulation of stat2 expression |
| 06/10/2004 | WO2004048523A2 Modulation of ku86 expression |
| 06/10/2004 | WO2004048522A2 Modulation of huntingtin interacting protein 2 expression |
| 06/10/2004 | WO2004048514A2 Methods for analyzing a nucleic acid |
| 06/10/2004 | WO2004048511A2 Bioinformatically detectable group of novel viral regulatory genes and uses thereof |
| 06/10/2004 | WO2004048451A2 Optical information carrier comprising immobilized proteorhodopsin |
| 06/10/2004 | WO2004048432A2 Preparation of polyphosphazene microspheres |
| 06/10/2004 | WO2004048397A2 Detectable labeled nucleoside analogs and methods of use thereof |
| 06/10/2004 | WO2004048376A1 Bicyclic naphthylidine nucleosides |
| 06/10/2004 | WO2004048325A2 Modulation of jagged 1 expression |
| 06/10/2004 | WO2004048256A2 Separation of carbon nanotubes dispersed by nucleic acids |
| 06/10/2004 | WO2004048255A2 Dispersion of carbon nanotubes by nucleic acids |
| 06/10/2004 | WO2004047978A2 1microarrays and production thereof |
| 06/10/2004 | WO2004047857A1 Use of fgf-18 in the diagnosis and treatment of memory disorders |
| 06/10/2004 | WO2004047767A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004047764A2 Modulation of hiv replication by rna interference |
| 06/10/2004 | WO2004047759A2 Composition for treating chlamydia infections and method for identifying same |
| 06/10/2004 | WO2004047757A2 Diagnosing and treating hematopoietic cancers |
| 06/10/2004 | WO2004047754A2 Loc169505 as modifier of the apc and axin pathways and methods of use |
| 06/10/2004 | WO2004047747A2 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 06/10/2004 | WO2004047746A2 Regulation of stearoyl-coa desaturase to treat obesity |
| 06/10/2004 | WO2004047742A2 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
| 06/10/2004 | WO2004047736A2 Modulation of bcl2-associated athanogene expression |
| 06/10/2004 | WO2004047731A2 Modulation of notch3 expression |
| 06/10/2004 | WO2004047728A2 Compositions and methods for the treatment of immune related diseases |
| 06/10/2004 | WO2004047727A2 Compositions and methods for diagnosing and treating mood disorders |
| 06/10/2004 | WO2004047721A2 A process for preparation of an agglutination reagent for rapid detection of typhoid |
| 06/10/2004 | WO2004047623A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004047614A2 Methods, biosensors and kits for detecting and identifying fungi |
| 06/10/2004 | WO2004047514A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004035803A9 Method and nucleic acids for the treatment of breast cell proliferative disorders |
| 06/10/2004 | WO2004034055A3 Method for detecting and limiting breast carcinoma risk by a micronucleus test of binuclear cells |
| 06/10/2004 | WO2004033717B1 Autism gene |
| 06/10/2004 | WO2004031366A3 Manufacturing method and readout system for biopolymer arrays |
| 06/10/2004 | WO2004029576A3 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 06/10/2004 | WO2004027372A3 Method for diagnosing rhabdomyosarcoma and pharmaceutical compositions for the treatment and/or prevention of rhabdomyosarcoma |
| 06/10/2004 | WO2004025560B1 Assay stick comprising coded microbeads |
| 06/10/2004 | WO2004022720A8 Methods for identifying antimicrobial compounds |
| 06/10/2004 | WO2004019037A3 Method for analyzing body fluids for the presence of cancer cells, use thereof, corresponding analysis kits, and use of specific active substances for treating cancer |
| 06/10/2004 | WO2004018996A3 High-throughput assay of hematopoietic stem and progenitor cell proliferation |
| 06/10/2004 | WO2004018704A3 Point source biological agent detection system |
| 06/10/2004 | WO2004017810A3 Tumor specific oligosaccharide epitopes and use thereof |
| 06/10/2004 | WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/10/2004 | WO2004012847A8 Sim2 polypeptides and polynucleotides and uses of each in diagnosis and treatment of ovarian, breast and lung cancers |
| 06/10/2004 | WO2004011900A3 Detecting receptor oligomerization |
| 06/10/2004 | WO2004003235A3 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 06/10/2004 | WO2004003171A3 Analysis and modification of gene expression in marine invertebrate cells |
| 06/10/2004 | WO2004000995A3 Methods, probes, and accessory molecules for detecting single nucleotide polymorphisms |
| 06/10/2004 | WO2003106632A3 Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 06/10/2004 | WO2003106476A8 Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activity |
| 06/10/2004 | WO2003103480A9 Gene cluster analysis for coronary artery disease |